Literature DB >> 24671374

Comparison of the performance of the different classification criteria for primary Sjögren's syndrome: a prospective cohort study.

Martina Plešivčnik Novljan1, Ziga Rotar, Aleš Ambrožič, Gaj Vidmar, Matija Tomšič.   

Abstract

The objective of the study is to compare the longitudinal performance of different classification criteria for primary Sjögren's syndrome (SS) in a cohort of patients previously diagnosed with primary SS. In each patient, we repeated diagnostic tests as required by the Copenhagen, European, Californian, and American-European Consensus Group (AECG) or the new American College of Rheumatology (ACR) classification criteria. Sixty-three out of 90 eligible patients (70 %) consented to participate. During the follow-up (mean (standard deviation, SD) 7.6 years (0.5)), we observed evolution from primary SS to SS with another systemic autoimmune disease (SAD) in 9/63 (14 %) patients, on average after 4.0 years (SD 0.9). The evolution from primary SS to SS-SADs was significantly more common if the diagnosis of primary SS was initially made using AECG (17 %, p = 0.008) or ACR (16 %, p = 0.016) criteria. In the 34 patients who underwent a full diagnostic reassessment, the diagnosis retention rate was statistically significant for all the criteria, except the European criteria. At reassessment, 3/32 (9 %) patients initially diagnosed as having primary SS using the European criteria could not be classified as having primary SS by any of the criteria. The differences in classification when using the AECG and the new ACR criteria were not statistically significant. The longitudinal diagnosis retention rate was highest for the Californian and AECG criteria. Regardless of the classification criteria, some patients eventually develop another SAD.

Entities:  

Mesh:

Year:  2014        PMID: 24671374     DOI: 10.1007/s10067-014-2549-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Classification criteria for Sjogren's syndrome: a critical review.

Authors:  Chiara Baldini; Rosaria Talarico; Athanasios G Tzioufas; Stefano Bombardieri
Journal:  J Autoimmun       Date:  2011-12-30       Impact factor: 7.094

3.  Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria.

Authors:  Henning Locht; Randi Pelck; Rolf Manthorpe
Journal:  Autoimmun Rev       Date:  2005-01-06       Impact factor: 9.754

4.  American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Authors:  S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

5.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

6.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

7.  Sjögren's syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria.

Authors:  J G Brun; T M Madland; C B Gjesdal; L-T Bertelsen
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

8.  Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.

Authors:  Vasiliki-Kalliopi K Bournia; Konstantina D Diamanti; Panayiotis G Vlachoyiannopoulos; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2010-03-13       Impact factor: 5.156

9.  Preliminary diagnostic criteria for Sjögren's syndrome.

Authors:  F N Skopouli; A A Drosos; T Papaioannou; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

10.  Comparison of the different classification criteria sets for primary Sjögren's syndrome.

Authors:  M P Novljan; B Rozman; M Jerse; Z Rotar; G Vidmar; T Kveder; M Tomsic
Journal:  Scand J Rheumatol       Date:  2006 Nov-Dec       Impact factor: 3.641

View more
  3 in total

1.  Total glucosides of peony ameliorates Sjögren's syndrome by affecting Th1/Th2 cytokine balance.

Authors:  Guolin Wu; Nayuan Wu; Tianyi Li; Wenwen Lu; Guoyou Yu
Journal:  Exp Ther Med       Date:  2016-01-22       Impact factor: 2.447

2.  Retention strategies in longitudinal cohort studies: a systematic review and meta-analysis.

Authors:  Samantha Teague; George J Youssef; Jacqui A Macdonald; Emma Sciberras; Adrian Shatte; Matthew Fuller-Tyszkiewicz; Chris Greenwood; Jennifer McIntosh; Craig A Olsson; Delyse Hutchinson
Journal:  BMC Med Res Methodol       Date:  2018-11-26       Impact factor: 4.615

3.  Plant-Derived Chimeric Virus Particles for the Diagnosis of Primary Sjögren Syndrome.

Authors:  Elisa Tinazzi; Matilde Merlin; Caterina Bason; Ruggero Beri; Roberta Zampieri; Chiara Lico; Elena Bartoloni; Antonio Puccetti; Claudio Lunardi; Mario Pezzotti; Linda Avesani
Journal:  Front Plant Sci       Date:  2015-12-01       Impact factor: 5.753

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.